Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients

Nav

General Info

Geography

Taiwan (Province of China) (TWN)

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

COVID-19

Citation

Authors

Ho HL, Wang FY, Lee HR, Huang YL, Lai CL, Jen WC, Hsieh SL, Chou TY

Journal

Lancet Reg Health West Pac

Volume

Pages

100041

Publication year

2020

Suggested citation

Ho HL, Wang FY, Lee HR, Huang YL, Lai CL, Jen WC, Hsieh SL, Chou TY. Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients. Lancet Reg Health West Pac. 2020; 3: 100041.

DOI

10.1016/j.lanwpc.2020.100041

PMID

34173603

GHDx Entry last modified on: Mar 14, 2022

Header sites

Search form

Main menu

Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients

Nav